You are here: Industry Insights > FDA

News List

US Drugmaker Trevena’s Ultra-Strong Painkiller Begins Final-Stage Trials in China firstwordpharma
July 08, 2021
Treneva's TRV-130 has entered Phase III trials in China, as reported Yicai Global on Wednesday.
Novartis shifts Leqvio manufacturing to Austrian facility cphi-online
July 08, 2021
Pharma firm tells FDA tech transfer to its own facility in Schaftenau, Austria is underway after regulator highlighted concerns about third party CDMO site in Italy
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA prnasia
July 07, 2021
Eucure Biopharma announced that the U.S. Food and Drug Administration (FDA) has approved two phase II clinical trials for YH001 (anti-CTLA-4) and YH003 (anti-CD40) in the United States.
Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis drugs
July 07, 2021
Lupin announced today that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis in adults.
Recall of Chantix Due to Impurity americanpharmaceuticalreview
July 05, 2021
FDA is alerting patients and health care professionals to Pfizer’s voluntary recall of nine lots of the smoking cessation drug, varenicline (brand name Chantix), to the warehouse level.
FDA Approves Treatment Regimen for Most Prevalent Childhood Cancer americanpharmaceuticalreview
July 05, 2021
The FDA approved Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients who are allergic to the ...
Nonprofit Covid Clinic Continues to Open Testing Locations Amid Delta Variant Spread prnewswire
July 05, 2021
As state, county, and local sponsored testing sites across the country are being shuttered, California-based COVID Clinic is heading in the opposite direction by adding new testing locations every week.
Alembic Pharma gets USFDA final approval for Nitrofurantoin Capsules, USP (Macrocrystals) expresspharma
July 02, 2021
The capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.
Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis expresspharma
July 02, 2021
SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3 clinical trial.
FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma drugs
July 02, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page